Novo Nordisk later claimed this was a strategic choice
Post-LOE, you have 17 generic semaglutide brands fighting for shelf space, and none of them have Novos vast trial record the evidence on how the drug behaves in patients who also carry other conditions, what the industry calls comorbidities
No direct purchase option: You must go through third-party telehealth providers, adding markup costs and reducing transparency
doi: 10.3389/fmicb.2025.1632726 Received 21 May 2025 Accepted 29 July 2025 Published 25 August 2025 Volume 16 - 2025 Edited by Marie-Joelle Franoise Virolle, Centre National de la Recherche Scientifique (CNRS), France Reviewed by Maria Lobato, Polytechnic University of Valencia, Spain Richard Dormatey, CSIR Crops Research Istitute, Ghana Updates Copyright 2025 Prabhu, Naicker, Duong, Govender, Engelbrecht, Backer, Stoychev and van den Berg
This is not a poison in the total sense of the word because it has many benefits, and this is due to its composition being rich in proteins, peptides, enzymes, and other types of molecules in low concentrations that show promise in the treatment of numerous diseases and conditions
BPC-157 has demonstrated neuroprotective properties, protecting nerve cells from damage and supporting their regeneration
